Breaking News Instant updates and real-time market news.

GDDY

GoDaddy

$43.84

0.23 (0.53%)

, GDOT

Green Dot

$53.78

1.5675 (3.00%)

10:09
10/06/17
10/06
10:09
10/06/17
10:09

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoDaddy (GDDY) initiated with an Outperform at William Blair. 2. Green Dot (GDOT) initiated with a Buy at Craig-Hallum. 3. Abbott (ABT) reinstated with a Neutral at JPMorgan. 4. Caesars (CZR) initiated with a Neutral at Nomura Instinet. 5. Tech Data (TECD) initiated with a Buy at Pivotal Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

GDDY

GoDaddy

$43.84

0.23 (0.53%)

GDOT

Green Dot

$53.78

1.5675 (3.00%)

ABT

Abbott

$54.69

-0.23 (-0.42%)

CZR

Caesars

$13.10

-0.3 (-2.24%)

TECD

Tech Data

$91.44

-0.43 (-0.47%)

  • 10

    Oct

  • 18

    Oct

  • 08

    Nov

  • 29

    Nov

GDDY GoDaddy
$43.84

0.23 (0.53%)

08/25/17
08/25/17
NO CHANGE
Target $55

Buy
Jefferies names GoDaddy a top mid-cap pick, starts at Buy
As previously reported, Jefferies analyst Brent Thill initiated GoDaddy with a Buy rating in a note to investors after the market close yesterday, calling the stock "a rare, underappreciated mid-cap story" with the "trifecta" of consistent performance, strong cash flow generation, and a "compelling" valuation. He set a $55 price target on GoDaday shares.
08/25/17
08/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Walgreens Boots Alliance (WBA) initiated with a Buy and CVS Health (CVS) and Fred's (FRED) initiated with a Hold at Loop Capital. 2. Adobe (ADBE), Intuit (INTU), GoDaddy (GDDY) initiated with a Buy at Jefferies, while Mindbody (MB) was initiated with a Hold. 3. New Oriental Education (EDU), Bright Scholar (BEDU) and TAL Education (TAL) initiated with Overweight ratings at Morgan Stanley. 4. WellCare (WCG) coverage assumed with an Overweight at Cantor. 5. Dollar Tree (DLTR) and Dollar General (DG) reinstated with Buy ratings at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/24/17
JEFF
08/24/17
INITIATION
JEFF
Buy
GoDaddy initiated with a Buy at Jefferies
Jefferies analyst Brent Thill initiated GoDaddy with a Buy and a $55 price target.
10/05/17
WBLR
10/05/17
INITIATION
WBLR
Outperform
GoDaddy initiated with an Outperform at William Blair
William Blair analyst Matthew Pfau initiated GoDaddy with an Outperform rating.
GDOT Green Dot
$53.78

1.5675 (3.00%)

08/09/17
LSCM
08/09/17
UPGRADE
Target $44
LSCM
Buy
Green Dot upgraded to Buy from Hold at Lake Street
Lake Street analyst Josh Elving upgraded Green Dot to Buy and raised his price target for the shares to $44 from $41. Following the "strong" Q2 results, the analyst sees a optimistic outlook for a return to organic card growth coupled with greater load trends. William Blair this morning also upgraded Green Dot.
09/18/17
SBSH
09/18/17
NO CHANGE
Target $54
SBSH
Buy
Green Dot price target raised to $54 from $48 at Citi
Citi analyst Ashwin Shirvaikar raised his price target for Green Dot to $54 saying he's staying Buy-rated on the shares despite the 99% year-to-date rally. The analyst sees stabilization of the prepaid card portfolio and the company's plans to better utilize Green Dot Bank as positives.
09/20/17
RHCO
09/20/17
NO CHANGE
RHCO
Green Dot price target raised to $60 from $50 at SunTrust
SunTrust analyst Andrew W. Jeffrey, raised his price target on Green Dot after traveling with the company's management. The analyst says that the company's new products have increased its total available market, yield and EBITDA margin outlook. He keeps a Buy rating on the shares.
10/05/17
CHLM
10/05/17
INITIATION
Target $70
CHLM
Buy
Green Dot initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Bradley Berning initiated Green Dot with a Buy rating and $70 price target, noting that consumers are more comfortable opening digital accounts, as well as opening bank accounts with non-traditional providers, and saying he believes Green Dot trades at a 50% discount to its peers.
ABT Abbott
$54.69

-0.23 (-0.42%)

09/29/17
LEER
09/29/17
NO CHANGE
Target $57
LEER
Outperform
Dexcom shares oversold after dropping 33%, says Leerink
Leerink analyst Danielle Antalffy says her analysis confirms shares of Dexcom (DXCM) are oversold after yesterday's 33% pullback. Pricing pressure following Abbott's (ABT) continuous glucose monitor could be less bad than feared, Antalffy tells investors in a research note. She believes payers assign at least some incremental value to Dexcom's alerts/alarms and the ability to prevent catastrophic hypoglycemic events. It's possible, if not likely, that payers continue to pay for Dexcom sensors at current $10 per day levels, the analyst contends. She believes the stock at current levels provides an attractive entry point. Antalffy lowered her price target for Dexcom to $57 from $85 and keeps an Outperform rating on the name.
10/02/17
BMOC
10/02/17
NO CHANGE
BMOC
Dexcom expected to remain significant player in diabetes, says BMO Capital
After BMO Capital conducted a survey of 27 doctors, Joanne Wuensch, an analyst at the firm, says the data indicates that "DexCom's (DXCM) CGM devices should have their place in the diabetes treatment paradigm" following the FDA's approval of Abbott's (ABT) competing Libre product. Specifically, the survey shows that overall CGM prescriptions will increase, while DexCom will maintain a 34% share of type 1 CGM allocations and a 25% share of type 2 allocations, according to Wuensch, The analyst expects DexCom's revenue to rise 23% next year and 18% in 2019. She keeps an Outperform rating on the stock.
10/06/17
JPMS
10/06/17
INITIATION
Target $60
JPMS
Neutral
Abbott reinstated with a Neutral at JPMorgan
JPMorgan analyst Michael Weinstein reinstated Abbott Laboratories with a Neutral rating and $60 price target. The analyst views the company as a 5.0% organic sales grower with the ability to deliver low double-digit earnings growth in 2018-2019 on acquisition synergies and deleveraging.
09/28/17
WBLR
09/28/17
NO CHANGE
WBLR
Outperform
William Blair sees Dexcom retaining advantage over Abbott
William Blair analyst Margaret Kaczor says that while she didn't think Abbott's (ABT) Libre Flash Glucose Monitoring device would receive a dosing claim given the product's "inferior accuracy," Libre still lacks DexCom's (DXCM) alerts and alarms that proactively protect the patient from glycemic excursions. Libre's dosing may shift the competitive dynamic "modestly in Abbott's favor versus Street expectations," but more importantly, its approval should be market expansive as it creates a new type of glucose monitoring category in the United States, Kaczor tells investors in a research note. The analyst believes DexCom will retain a "material technological and brand advantage." Further, the company has a "rich product pipeline" including its own 10-day G6 sensor that is nearing approval, the analyst adds. She keeps an Outperform rating on Dexcom. Kaczor thinks the stock, at last night's price between $55 and $56, adequately prices in risk of share loss in the category. Dexcom in premarket trading is down 29% to $47.93.
CZR Caesars
$13.10

-0.3 (-2.24%)

10/06/17
NOMU
10/06/17
INITIATION
Target $14
NOMU
Neutral
Caesars initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Brian Dobson started Caesars Entertainment with a Neutral rating and $14 price target. The analyst believes the company's growth catalysts are largely discounted in the shares.
07/19/17
07/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyson Foods (TSN) reinstated with a Neutral at Credit Suisse. 2. Bob Evans (BOBE) initiated with a Buy at Berenberg. 3. Quanex (NX) coverage assumed with an Outperform at Wedbush. 4. Agile Therapeutics (AGRX) initiated with a Buy at H.C. Wainwright. 5. Caesars (CZR) re-initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/17
WOLF
07/21/17
INITIATION
Target $16
WOLF
Outperform
Caesars initiated with an Outperform at Wolfe Research
Wolfe initiated Caesars with an Outperform and a $16 price target.
09/15/17
RHCO
09/15/17
INITIATION
Target $14
RHCO
Buy
Caesars initiated with a Buy at SunTrust
SunTrust analyst Patrick Scholes initiated Caesars with a Buy and a $14 price target given his positive view on regional gaming and Vegas strip fundamentals: Scholes believes US gaming is a consolidating industry and Caesars could emerge as a leading consolidator and also purse sale-leaseback opportunities.
TECD Tech Data
$91.44

-0.43 (-0.47%)

10/06/17
PIVT
10/06/17
INITIATION
Target $114
PIVT
Buy
Tech Data initiated with a Buy at Pivotal Research
Pivotal Research analyst Lou Miscioscia initiated Tech Data with a Buy and $114 price target. The analyst believes Tech Data is poised for improving results following the July quarter miss and given the multi-year low valuation, and massive accretion of the ramping TS business, deserves a Buy rating.
09/18/17
NEED
09/18/17
INITIATION
NEED
Buy
Tech Data coverage assumed with a Buy at Needham
Needham analyst Sean Hannan assumed coverage of Tech Data with a $100 price target and a Buy rating. The analyst blames the company's "disappointing" Q2 results and guidance primarily on short-term issues. He calls the company " a leading global technology distributor that offers 1-stop shopping for its large customer base" and believes that it can benefit from a number of tech trends, including the cloud and security. Hannan identifies the stock as his top pick in the reseller/distributor space.
09/05/17
NRCS
09/05/17
UPGRADE
NRCS
Buy
Tech Data upgraded to Buy from Neutral at Northcoast
09/01/17
BOFA
09/01/17
NO CHANGE
BOFA
Tech Data shares should rebound, says BofA/Merrill
After Tech Data's reported Q2 EPS that missed expectations due to lower than expected margins and the shares fell 20% after hours,BofA/Merrill analyst Param Singh blames the miss on "lower profits from a high margin rebate program, currency-related costs in its components business and increased competitive pressure. " Singh expects the component business issue to disappear by the end of this year and predicts that the rebate pressure will ease by the end of 2017. The analyst expects the stock to rebound from the after hours level and keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

08:23
09/24/18
09/24
08:23
09/24/18
08:23
Conference/Events
Evercore ISI to hold a field trip »

Consumer Retail Field…

ARCB

ArcBest

$46.55

-0.5 (-1.06%)

, BOFI

BofI Holding

$35.82

-0.66 (-1.81%)

08:22
09/24/18
09/24
08:22
09/24/18
08:22
Conference/Events
Stephens to hold a forum »

8th Annual Bank CEO Forum…

ARCB

ArcBest

$46.55

-0.5 (-1.06%)

BOFI

BofI Holding

$35.82

-0.66 (-1.81%)

BY

Byline Bancorp

$23.21

0.33 (1.44%)

CARO

Carolina Financial

$39.73

0.15 (0.38%)

CSFL

CenterState Bank

$30.55

-0.34 (-1.10%)

FBK

FB Financial

$44.00

-0.34 (-0.77%)

HTH

Hilltop Holdings

$21.06

0.08 (0.38%)

NBHC

National Bank

$37.97

-0.07 (-0.18%)

NCOM

National Commerce

$43.50

-0.5 (-1.14%)

OLBK

Old Line Bancshares

$33.20

-0.67 (-1.98%)

ICBK

County Bancorp

$25.01

0.08 (0.32%)

LION

Fidelity Southern

$25.58

0.38 (1.51%)

MSBI

Midland States

$33.10

-0.68 (-2.01%)

TBK

Triumph Bancorp

$41.68

-2.825 (-6.35%)

STL

Sterling Bancorp

$23.10

(0.00%)

VBTX

Veritex

$29.65

-0.73 (-2.40%)

WTFC

Wintrust Financial

$90.36

-0.35 (-0.39%)

TSC

TriState Capital

$28.45

0.05 (0.18%)

RNST

Renasant

$43.69

-0.59 (-1.33%)

SFNC

Simmons First National

$31.75

-0.2 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 27

    Sep

  • 08

    Oct

  • 23

    Oct

  • 29

    Oct

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

CYDY

CytoDyn

$0.00

(0.00%)

, CODX

Co-Diagnostics

$2.65

-0.1 (-3.64%)

08:21
09/24/18
09/24
08:21
09/24/18
08:21
Conference/Events
Catalyst Research Management Group to hold a roundup »

4th Annual Robins Equity…

CYDY

CytoDyn

$0.00

(0.00%)

CODX

Co-Diagnostics

$2.65

-0.1 (-3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
09/24/18
09/24
08:21
09/24/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGHT

8x8, Inc.

$21.20

-0.5 (-2.30%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Hot Stocks
8x8, Inc. appoints Matthew Zinn as General Counsel, Chief Privacy Officer »

8x8, Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

ABT

Abbott

$69.05

0.25 (0.36%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Recommendations
Abbott analyst commentary  »

Abbott's COAPT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KVHI

KVH Industries

$12.15

(0.00%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Upgrade
KVH Industries rating change  »

KVH Industries upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$119.47

0.26 (0.22%)

, WFT

Weatherford

$2.64

0.075 (2.92%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Conference/Events
Credit Suisse to hold a non tour »

4th Annual Oil & Gas…

EOG

EOG Resources

$119.47

0.26 (0.22%)

WFT

Weatherford

$2.64

0.075 (2.92%)

OXY

Occidental Petroleum

$79.62

0.37 (0.47%)

COG

Cabot Oil & Gas

$23.22

0.32 (1.40%)

NFX

Newfield Exploration

$29.04

0.6 (2.11%)

FRAC

Keane Group

$12.54

0.01 (0.08%)

MRO

Marathon Oil

$21.86

0.31 (1.44%)

MUR

Murphy Oil

$32.17

0.37 (1.16%)

SLB

Schlumberger

$61.14

-0.44 (-0.71%)

APC

Anadarko

$64.63

0.77 (1.21%)

NOV

National Oilwell

$43.15

0.25 (0.58%)

RIG

Transocean

$13.54

0.91 (7.21%)

HES

Hess Corp.

$70.47

1.11 (1.60%)

NBR

Nabors Industries

$6.24

-0.05 (-0.79%)

OAS

Oasis Petroleum

$12.97

0.19 (1.49%)

COP

ConocoPhillips

$76.12

0.75 (1.00%)

APA

Apache

$45.95

0.285 (0.62%)

BHGE

Baker Hughes

$32.89

0.42 (1.29%)

HA

Hawaiian Holdings

$40.15

-0.05 (-0.12%)

CVX

Chevron

$121.07

1.61 (1.35%)

FTI

TechnipFMC

$31.20

(0.00%)

HAL

Halliburton

$40.70

0.31 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 26

    Sep

  • 29

    Sep

  • 01

    Oct

  • 04

    Oct

  • 05

    Oct

  • 19

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 29

    Oct

  • 02

    Nov

IYT

iShares Transportation Average

$207.93

0.52 (0.25%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

08:20
09/24/18
09/24
08:20
09/24/18
08:20
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

08:19
09/24/18
09/24
08:19
09/24/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

08:19
09/24/18
09/24
08:19
09/24/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APA

Apache

$45.95

0.285 (0.62%)

, BAS

Basic Energy

$9.26

0.12 (1.31%)

08:19
09/24/18
09/24
08:19
09/24/18
08:19
Conference/Events
Johnson Rice to hold a conference »

2018 Johnson Rice Energy…

APA

Apache

$45.95

0.285 (0.62%)

BAS

Basic Energy

$9.26

0.12 (1.31%)

CLR

Continental Resources

$62.28

0.515 (0.83%)

DNR

Denbury Resources

$5.60

0.06 (1.08%)

HAL

Halliburton

$40.70

0.31 (0.77%)

CRZO

Carrizo Oil & Gas

$25.63

0.42 (1.67%)

TDW

Tidewater

$31.10

0.005 (0.02%)

NR

Newpark Resources

$9.95

(0.00%)

CRK

Comstock Resources

$8.95

0.31 (3.59%)

EPM

Evolution Petroleum

$11.10

0.35 (3.26%)

PXD

Pioneer Natural

$172.57

1.19 (0.69%)

QEP

QEP Resources

$11.09

0.15 (1.37%)

RES

RPC, Inc.

$15.66

0.2 (1.29%)

PE

Parsley Energy

$28.80

0.25 (0.88%)

WPX

WPX Energy

$18.44

0.015 (0.08%)

SN

Sanchez Energy

$2.59

-0.09 (-3.36%)

ROSE

Rosehill Resources

$8.20

-0.37 (-4.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 03

    Oct

  • 22

    Oct

  • 07

    Nov

  • 28

    Sep

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

08:19
09/24/18
09/24
08:19
09/24/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

08:18
09/24/18
09/24
08:18
09/24/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

08:18
09/24/18
09/24
08:18
09/24/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

08:18
09/24/18
09/24
08:18
09/24/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$92.27

-0.42 (-0.45%)

, AZN

AstraZeneca

$37.69

-0.025 (-0.07%)

08:18
09/24/18
09/24
08:18
09/24/18
08:18
Conference/Events
International Association for Study of Lung Cancer »

19th World Conference on…

ABBV

AbbVie

$92.27

-0.42 (-0.45%)

AZN

AstraZeneca

$37.69

-0.025 (-0.07%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$62.24

0.5 (0.81%)

CELG

Celgene

$87.68

-0.65 (-0.74%)

LOXO

Loxo Oncology

$159.16

-0.14 (-0.09%)

MRK

Merck

$71.11

0.315 (0.44%)

NEO

NeoGenomics

$14.24

-0.26 (-1.79%)

NVCR

Novocure

$48.65

-0.55 (-1.12%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

PFE

Pfizer

$44.06

0.3 (0.69%)

SPPI

Spectrum

$21.37

-0.15 (-0.70%)

RHHBY

Roche

$0.00

(0.00%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

TMO

Thermo Fisher

$243.41

0.91 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 29

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 26

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

IWM

iShares Trust Russell 2000 Index Fund

$170.41

-0.81 (-0.47%)

08:17
09/24/18
09/24
08:17
09/24/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$267.08

0.6458 (0.24%)

08:17
09/24/18
09/24
08:17
09/24/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMED

OncoMed

$2.39

-0.005 (-0.21%)

08:17
09/24/18
09/24
08:17
09/24/18
08:17
Hot Stocks
OncoMed announces publication of Phase 1a data for navicixizumab »

OncoMed announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

08:17
09/24/18
09/24
08:17
09/24/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$138.62

-2.92 (-2.06%)

08:17
09/24/18
09/24
08:17
09/24/18
08:17
Conference/Events
Workday management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.